- Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipientsRami T Bustami
Scientific Registry of Transplant Recipients University Renal Research and Education Association, Ann Arbor, MI, USA
Am J Transplant 4:87-93. 2004..024). These new estimates of the magnitude of malignancy risk associated with induction therapy may be useful for clinical practice...
- Immunosuppression: evolution in practice and trends, 1993-2003Ron Shapiro
Thomas E Starzl Transplant, University of Pittsburgh, Pittsburgh, PA, USA
Am J Transplant 5:874-86. 2005....